{"cik":"0001815442","ticker":"KYMR","name":"Kymera Therapeutics, Inc.","sic_code":"2836","sic_description":"Biological Products, (No Diagnostic Substances)","exchange":"Nasdaq","state_of_incorporation":"DE","fiscal_year_end":"1231","first_filing_date":"2026-05-15","last_filing_date":"2026-09-08","url":"/sec/cik-0001815442","insider_summary":{"total_transactions":297,"unique_insiders":26,"latest_transaction":"2026-07-07"},"recent_filings":[{"accession_number":"0001193125-26-295090","form_type":"4","form_type_family":"insider","doc_date":"2026-07-02","title":"4 — Kymera Therapeutics, Inc. — 2026-07-02","url_slug":"/sec/cik-0001815442/4/0001193125-26-295090","edgar_url":"https://www.sec.gov/Archives/edgar/data/1815442/0001193125-26-295090-index.html"},{"accession_number":"0001193125-26-295089","form_type":"4","form_type_family":"insider","doc_date":"2026-07-02","title":"4 — Kymera Therapeutics, Inc. — 2026-07-02","url_slug":"/sec/cik-0001815442/4/0001193125-26-295089","edgar_url":"https://www.sec.gov/Archives/edgar/data/1815442/0001193125-26-295089-index.html"},{"accession_number":"0001193125-26-295088","form_type":"4","form_type_family":"insider","doc_date":"2026-07-02","title":"4 — Kymera Therapeutics, Inc. — 2026-07-02","url_slug":"/sec/cik-0001815442/4/0001193125-26-295088","edgar_url":"https://www.sec.gov/Archives/edgar/data/1815442/0001193125-26-295088-index.html"},{"accession_number":"0001969223-26-000752","form_type":"144","form_type_family":"other","doc_date":"2026-07-02","title":"144 — Kymera Therapeutics, Inc. — 2026-07-02","url_slug":"/sec/cik-0001815442/144/0001969223-26-000752","edgar_url":"https://www.sec.gov/Archives/edgar/data/1815442/0001969223-26-000752-index.html"},{"accession_number":"0001950047-26-006765","form_type":"144","form_type_family":"other","doc_date":"2026-07-01","title":"144 — Kymera Therapeutics, Inc. — 2026-07-01","url_slug":"/sec/cik-0001815442/144/0001950047-26-006765","edgar_url":"https://www.sec.gov/Archives/edgar/data/1815442/0001950047-26-006765-index.html"},{"accession_number":"0001950047-26-006647","form_type":"144","form_type_family":"other","doc_date":"2026-06-30","title":"144 — Kymera Therapeutics, Inc. — 2026-06-30","url_slug":"/sec/cik-0001815442/144/0001950047-26-006647","edgar_url":"https://www.sec.gov/Archives/edgar/data/1815442/0001950047-26-006647-index.html"},{"accession_number":"0001628280-26-046098","form_type":"144","form_type_family":"other","doc_date":"2026-06-29","title":"144 — Atlas Venture Opportunity Fund I, L.P. — 2026-06-29","url_slug":"/sec/cik-0001759241/144/0001628280-26-046098","edgar_url":"https://www.sec.gov/Archives/edgar/data/1815442/0001628280-26-046098-index.html"},{"accession_number":"0001950047-26-006511","form_type":"144","form_type_family":"other","doc_date":"2026-06-25","title":"144 — Kymera Therapeutics, Inc. — 2026-06-25","url_slug":"/sec/cik-0001815442/144/0001950047-26-006511","edgar_url":"https://www.sec.gov/Archives/edgar/data/1815442/0001950047-26-006511-index.html"},{"accession_number":"0001193125-26-283140","form_type":"4","form_type_family":"insider","doc_date":"2026-06-25","title":"4 — Kymera Therapeutics, Inc. — 2026-06-25","url_slug":"/sec/cik-0001815442/4/0001193125-26-283140","edgar_url":"https://www.sec.gov/Archives/edgar/data/1815442/0001193125-26-283140-index.html"},{"accession_number":"0001193125-26-283139","form_type":"4","form_type_family":"insider","doc_date":"2026-06-25","title":"4 — Kymera Therapeutics, Inc. — 2026-06-25","url_slug":"/sec/cik-0001815442/4/0001193125-26-283139","edgar_url":"https://www.sec.gov/Archives/edgar/data/1815442/0001193125-26-283139-index.html"},{"accession_number":"0001193125-26-283138","form_type":"4","form_type_family":"insider","doc_date":"2026-06-25","title":"4 — Ridloff Elena — 2026-06-25","url_slug":"/sec/cik-0001772518/4/0001193125-26-283138","edgar_url":"https://www.sec.gov/Archives/edgar/data/1815442/0001193125-26-283138-index.html"},{"accession_number":"0001193125-26-283136","form_type":"4","form_type_family":"insider","doc_date":"2026-06-25","title":"4 — Albers Jeffrey W. — 2026-06-25","url_slug":"/sec/cik-0001638474/4/0001193125-26-283136","edgar_url":"https://www.sec.gov/Archives/edgar/data/1815442/0001193125-26-283136-index.html"},{"accession_number":"0001193125-26-281051","form_type":"8-K","form_type_family":"current","doc_date":"2026-06-24","title":"8-K — Kymera Therapeutics, Inc. — 2026-06-24","url_slug":"/sec/cik-0001815442/8-k/0001193125-26-281051","edgar_url":"https://www.sec.gov/Archives/edgar/data/1815442/0001193125-26-281051-index.html"},{"accession_number":"0001628280-26-044985","form_type":"144","form_type_family":"other","doc_date":"2026-06-23","title":"144 — Atlas Venture Opportunity Fund I, L.P. — 2026-06-23","url_slug":"/sec/cik-0001759241/144/0001628280-26-044985","edgar_url":"https://www.sec.gov/Archives/edgar/data/1815442/0001628280-26-044985-index.html"},{"accession_number":"0001193125-26-277766","form_type":"4","form_type_family":"insider","doc_date":"2026-06-22","title":"4 — Kymera Therapeutics, Inc. — 2026-06-22","url_slug":"/sec/cik-0001815442/4/0001193125-26-277766","edgar_url":"https://www.sec.gov/Archives/edgar/data/1815442/0001193125-26-277766-index.html"},{"accession_number":"0001950047-26-006382","form_type":"144","form_type_family":"other","doc_date":"2026-06-22","title":"144 — Kymera Therapeutics, Inc. — 2026-06-22","url_slug":"/sec/cik-0001815442/144/0001950047-26-006382","edgar_url":"https://www.sec.gov/Archives/edgar/data/1815442/0001950047-26-006382-index.html"},{"accession_number":"0001193125-26-261698","form_type":"8-K","form_type_family":"current","doc_date":"2026-06-08","title":"8-K — Kymera Therapeutics, Inc. — 2026-06-08","url_slug":"/sec/cik-0001815442/8-k/0001193125-26-261698","edgar_url":"https://www.sec.gov/Archives/edgar/data/1815442/0001193125-26-261698-index.html"},{"accession_number":"0001193125-26-254589","form_type":"4","form_type_family":"insider","doc_date":"2026-06-03","title":"4 — Kymera Therapeutics, Inc. — 2026-06-03","url_slug":"/sec/cik-0001815442/4/0001193125-26-254589","edgar_url":"https://www.sec.gov/Archives/edgar/data/1815442/0001193125-26-254589-index.html"},{"accession_number":"0001897612-26-000493","form_type":"SCHEDULE 13G","form_type_family":"other","doc_date":"2026-05-15","title":"SCHEDULE 13G — Kymera Therapeutics, Inc. — 2026-05-15","url_slug":"/sec/cik-0001815442/schedule-13g/0001897612-26-000493","edgar_url":"https://www.sec.gov/Archives/edgar/data/1815442/0001897612-26-000493-index.html"},{"accession_number":"0000902219-26-000204","form_type":"SCHEDULE 13G/A","form_type_family":"other","doc_date":"2026-05-15","title":"SCHEDULE 13G/A — Kymera Therapeutics, Inc. — 2026-05-15","url_slug":"/sec/cik-0001815442/schedule-13g-a/0000902219-26-000204","edgar_url":"https://www.sec.gov/Archives/edgar/data/1815442/0000902219-26-000204-index.html"}],"related_endpoints":{"profile":"/sec/KYMR/profile","timeline":"/sec/KYMR/timeline","peers":"/sec/KYMR/peers","insider_pulse":"/sec/KYMR/insider-pulse","insider_summary":"/sec/KYMR/insider-summary","insider_transactions":"/sec/KYMR/insider-transactions","form144":"/sec/KYMR/form144","holdings_as_filer":"/sec/KYMR/holdings","financial_facts":"/sec/KYMR/financial-facts","derivatives":"/sec/KYMR/derivatives","officers":"/sec/KYMR/officers","insider_network":"/sec/KYMR/insider-network","risk_flags":"/sec/KYMR/risk-flags","filings":"/sec/KYMR/filings","cross_topic_dossier":"/api/v1/dossier?ticker=KYMR"}}